Lombard Odier Asset Management (USA)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-719,112	Closed	-$6.98M	–	171
2015 Q4	$6.98M	Sell	719,112 -738,565	-51%	-$7.14M	0.68%	64
2015 Q3	$12.7M	Buy	1,457,677 +852,052	+141%	+$7.95M	1.11%	25
2015 Q2	$6.12M	Buy	+605,625	New	+$7.04M	0.43%	74
2015 Q1	–	Sell	-485,613	Closed	-$6.23M	–	189
2014 Q4	$6.23M	Buy	485,613 +97,563	+25%	+$1.12M	0.43%	67
2014 Q3	$4.21M	Buy	+388,050	New	+$4.44M	0.29%	101

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s IRWD Position: Q1 2016 in Review

Lombard Odier Asset Management (USA) sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2016, closing a stake of 719,112 shares — an estimated $6.98M sold.

Lombard Odier Asset Management (USA) first reported a position in IRWD in Q3 2014 and held it in 5 quarters. The position peaked at $12.7M in Q3 2015. 136 funds tracked by Wall St. Rank hold IRWD as of Q1 2016.

Lombard Odier Asset Management (USA) reported no remaining Ironwood Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 719,112 Ironwood Pharmaceuticals shares in Q1 2016, an estimated $6.98M.
Lombard Odier Asset Management (USA) first reported a position in Ironwood Pharmaceuticals in Q3 2014 and held it in 5 quarters.
Lombard Odier Asset Management (USA)'s Ironwood Pharmaceuticals position peaked at $12.7M in Q3 2015.
136 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2016, filed 16 May 2016.